Global Bird Flu Market Insights Forecasts to 2033

• The Global Bird Flu Market Size was Valued at USD 1.40 Billion in 2023
• The Market Size is Growing at a CAGR of 4.53% from 2023 to 2033
• The Worldwide Bird Flu Market Size is Expected to Reach USD 2.18 Billion by 2033
• North America is Expected to Grow the fastest during the forecast period.

The Global Bird Flu Market Size is Anticipated to Exceed USD 2.18 Billion by 2033, Growing at a CAGR of 4.53% from 2023 to 2033. The global bird flu market is expected to have high growth due to increased investment in vaccine development, especially concerning high-risk strains such as H5N1. Asia Pacific holds the highest share due to frequent outbreaks and robust prevention efforts. North America is the second-fastest-growing region, with government-led surveillance and advanced vaccine technologies.   

Market Overview

Bird flu is a viral infection caused by avian influenza viruses that mainly affects birds but may be passed on to humans and other animals. The global bird flu market encompasses products, services, and technologies that can be directed to the prevention, diagnosis, management, and treatment of avian influenza, popularly referred to as bird flu. This market ranges from vaccines and antiviral drugs, diagnostic tests and reagents, and healthcare products related to the health of animals and human beings. Furthermore, the global bird flu market will have vaccines, diagnostics, and treatments that control the spread of avian influenza, especially the dangerous strains H5N1 and H7N9. This market comprises key stakeholders such as healthcare providers, veterinary clinics, diagnostic laboratories, pharmaceutical companies, poultry farms, and government agencies focused on preventing zoonotic diseases and being ready for pandemics.

In response to rising bird flu cases, governments are ramping up efforts to develop vaccines and strengthen their preparedness. Notably, the U.S. government has awarded Moderna a $176 million contract to expedite the development of an mRNA-based vaccine for the H5N1 avian influenza. This funding will support late-stage development and testing of the vaccine, aiming to address the pandemic potential of the virus.

Opportunities and Trends in the Bird Flu Market: 

Opportunities in the avian flu market arise from innovations in vaccine technology, including such instant-response mechanisms as mRNA vaccines. Government investments in vaccine stockpiles and preparedness programs represent specific growth opportunities across the US and Europe. The increased public awareness of the risk posed by avian influenza increases the demand for better surveillance and preventive measures.

Challenges in the Market for the Bird Flu Market:

High hurdles in the bird flu market are making it difficult to control the virus such as mutation patterns leading to challenges in developing universal vaccines, high production and distribution costs of vaccines, logistics issues in delivering vaccines to the stricken areas, and international cooperation along with management.

Report Coverage 

This research report categorizes the global bird flu market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global bird flu market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global bird flu market.  

Driving Factors

Driving factors in the bird flu market include increased government investment in vaccine research, particularly for mRNA technologies, and the growing need for pandemic preparedness due to the threat of avian influenza outbreaks. Additionally, advancements in rapid detection and global surveillance systems help mitigate the spread of the virus. Moreover, governments are making heavy investments in bird flu vaccine research in anticipation of the next major outbreak. The U.S. Department of Health and Human Services (HHS) recently contracted with CSL Seqirus to produce millions of doses of pre-pandemic H5N1 vaccine, based on cell-based vaccine technology improvements. That follows earlier agreements under the Biomedical Advanced Research and Development Authority (BARDA) to improve the response capabilities.

Restraining Factors

Restrictions in the bird flu market include a lack of funding for widespread vaccine distribution, which hampers vaccination programs worldwide. Approval policies for vaccines vary considerably from one country to another, thereby slowing down vaccine distribution. Full access to vaccines also faces problems in low-income countries, which slows responses to outbreaks worldwide.

Market Segmentation

The global bird flu market share is classified into virus type, test type, treatment type and animal type. 

•    The H5N1 segment is expected to hold the largest share of the global bird flu market during the forecast period.               

Based on the virus type, the global bird flu market is categorized as H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, and others. Among these, the H5N1 segment is expected to hold the largest share of the global bird flu market during the forecast period. This is due to its previous great impact on both human and avian populations, which remain on the watch and trying to produce vaccines. The H5N1 virus still is a threat requiring continued focus since it could become the cause of pandemics in the event that it undergoes mutation to be easily transmitted among humans. Secondly, the significant response toward the H5N1 outbreak and the government's continuous investment in research and development of vaccines continue to keep this specific strain as one of the market's most critical targets.

•    The next generation sequencing segment is expected to grow at the fastest CAGR during the forecast period.       

Based on the test type, the global bird flu market is categorized as PCR tests, ELISA tests, hemagglutination assays, virus isolation tests, next generation sequencing, and others. Among these, the next generation sequencing segment is expected to grow at the fastest CAGR during the forecast period. It has high capabilities for doing speedy and accurate genomic analysis, wherein NGS helps in highlighting the mutations viruses go through to help improve early diagnosis and surveillance. It might provide whole data on which virus evolution occurs, along with guiding vaccine development during its better preparation for the future spread of such diseases and Their cost-effectiveness, scalability, and high throughput also make it grow rapidly into infectious disease diagnostics and research. 

•    The vaccines segment is expected to hold the largest share of the global bird flu market during the forecast period.               
    
Based on treatment type, the global bird flu market is categorized as vaccines, antiviral medication, immunomodulators, and others. Among these, the vaccines segment is expected to hold the largest share of the global bird flu market during the forecast period. This is because such vaccines are critical in checking the spread of avian flu, particularly in high-risk areas. The international health community and governments are interested in vaccine development as a means of containing rapid outbreaks and have invested massive sums of money in the production of vaccines, including pre-pandemic vaccines for specific strains like H5N1 and H7N9.  

•    The chicken’s segment is expected to grow at the fastest CAGR during the forecast period.       
 
Based on the animal type, the global bird flu market is categorized as chickens, ducks, geese & swans, pigeons, guinea fowls, turkeys, and others. Among these, the chicken’s segment is expected to grow at the fastest CAGR during the forecast period. Chicken is also the most reported poultry bird species in outbreaks, therefore being the number one priority to be monitored for vaccination and control. A great deal of economic effects arises here as chicken is very largely kept in all types of commercial and small farms worldwide, therefore creating a great amount of demand for vaccines and antivirals plus all the preventive measures meant exclusively for chicken, thereby accelerating further the growth of this particular segment in the market.

Regional Segment Analysis of the Global Bird Flu Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

Asia Pacific is projected to hold the largest share of the global bird flu market over the forecast period.

Asia Pacific is projected to hold the largest share of the global bird flu market over the forecast period. This is primarily because the outbreaks of avian influenza are common in most countries, especially China, India, and Indonesia, due to the significance of the poultry industry. Furthermore, the high poultry population in the region and government initiatives into vaccination programs, surveillance, and rapid response systems contribute to the growth of the market. The control and mitigation measures taken at avian influenza and the increasing focus of the region towards vaccine development contribute to the growth.

North America is expected to grow at the fastest CAGR growth of the global bird flu market during the forecast period. This growth is due to ongoing monitoring and control efforts, especially in the U.S. and Canada, since poultry farming is a high-profile industry. Government agencies, like the U.S. Department of Agriculture (USDA), are primarily focused on the preparedness of avian influenza outbreaks, with sizeable investments in surveillance systems and vaccine development. Another reason is the continuous innovations with respect to vaccine technologies like mRNA and other advanced treatments.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global bird flu market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Ceva Sante Animale
• Zoetis
• Merck & Co.
• Ringpu Biology
• Yebio Bioengineering
• FATRO
• CAVAC
• ChengDu Tecbond
• QYH Biotech
• Elanco
• Phibro Animal Health
• Vetoquinol
• Hipra
• Anicon Labor GmbH
• Others 

Key Market Developments

• In September 2023, Wageningen Bioveterinary Research (WBVR) began an experiment using bird flu immunization. In the trial, vaccinations against the current H5 viruses are tested on laying hens. This initial immunization experiment takes place in the animal facilities of WBVR's high containment unit. The contemporary vaccinations were produced by three distinct pharmaceutical companies, and the tested vaccines use several technologies.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global bird flu market based on the below-mentioned segments: 

Global Bird Flu Market, By Virus Type

• H5N1
• H7N9
• H5N6
• H5N8
• H10N8
• H9N2
• Others

Global Bird Flu Market, By Test Type

• PCR Tests
• ELISA Tests
• Hemagglutination Assays
• Virus Isolation Tests
• Next Generation Sequencing
• Others

Global Bird Flu Market, By Treatment Type

• Vaccines
• Antiviral Medication
• Immunomodulators
• Others

Global Bird Flu Market, By Animal Type

• Chickens
• Ducks
• Geese & Swans
• Pigeons
• Guinea Fowls
• Turkeys
• Others

Global Bird Flu Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa